SOPHiA GENETICS Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-72.98	-78.98	-87.45	-73.68	-39.34	-33.79
Depreciation & Amortization	8.51	8.34	5.57	3.61	2.39	1.91
Share-Based Compensation	16.53	15.24	13.61	8.51	1.36	0.72
Other Operating Activities	0.39	6.83	-1.83	3.61	3.86	-0.52
Operating Cash Flow	-47.56	-48.58	-70.09	-57.94	-31.73	-31.68
Capital Expenditures	-1.09	-1.49	-4.1	-2.68	-0.45	-1.36
Change in Investments	1.33	17.55	52.35	-50.26	-21.12	0
Other Investing Activities	-8.37	-7.73	-6.28	-3.99	-2.75	-1.68
Investing Cash Flow	-8.12	8.32	41.97	-56.93	-24.32	-3.03
Share Issuance / Repurchase	0.26	0.23	0.75	235.84	108.72	1.76
Debt Issued / Paid	-2.74	-3.04	-2.32	-4.09	-1.67	-2.78
Other Financing Activities	-	-	-	6.02	-	-
Financing Cash Flow	-2.48	-2.82	-1.57	237.77	107.05	-1.02
Net Cash Flow	-58.23	-43.07	-29.69	122.9	50.99	-35.74
Free Cash Flow	-48.65	-50.07	-74.19	-60.62	-32.18	-33.04
Free Cash Flow Margin	-75.79%	-80.28%	-155.99%	-149.87%	-113.31%	-130.25%
Free Cash Flow Per Share	-0.75	-0.77	-1.16	-0.95	-0.51	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).